The Miami Entrepreneur

Eli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials

Read Time:8 Second

The pharmaceutical giant plans to present the trial data at an upcoming medical conference and submit them to the U.S. Food and Drug Administration mid-year. 

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Bitcoin’s Halving Is Coming. Miners Are Looking for New Ways to Make Money.
Next post Travelers’ stock suffers biggest selloff in 4 years after profit miss